HomeCreo Medical Group

Creo Medical Group

Creo Medical Group South African Framework Distribution Agreement with First Medical Company

7/9/18: Craig Gulliford, Creo’s Chief Executive Officer, commented: “This third agreement, alongside Hoya Group, Pentax Medical and Diagmed Healthcare, demonstrates the growing momentum in the commercialisation of our lead product, Speedboat RS2. With a rapidly growing distribution network, Creo is well placed to advance the emerging field of surgical endoscopy through our advanced energy platform, paving the way for our suite of minimally invasive GI devices under development. First Medical’s expertise and knowledge of the Southern African markets will prove invaluable to Creo as we continue to build our reputation worldwide.”